Clinical trial
Study of the BDNF- Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
NCT02146963 is registered in ClinicalTrials.gov with Centre Hospitalier Esquirol as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the BDNF- Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
- Lead sponsor
- Centre Hospitalier Esquirol
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- April 30, 2016
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence